Phase 2 Breast Cancer Trial, Recruiting NCT07376538 Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Condition: Breast Cancer
Back to Breast Cancer

Phase 2 Breast Cancer Trial, Recruiting

NCT07376538
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman between 18 and 75 years old
  • You are generally able to carry out daily activities with little or no limitation (confirm with trial site regarding specific activity level requirements)
  • You have been diagnosed with invasive breast cancer, confirmed through a tissue sample (biopsy)
  • You have newly diagnosed breast cancer that has spread to certain nearby lymph nodes — specifically the lymph nodes above the collarbone and/or near the breastbone — confirmed by biopsy or, in some cases, by scans and your doctor's assessment
  • You are planned to receive treatment before surgery (such as chemotherapy), followed by either breast-conserving surgery or full breast removal, plus removal of underarm lymph nodes
  • Your blood counts, kidney, liver, and clotting functions are all within acceptable levels (confirm with trial site for specific values)
  • You are willing and able to attend all required study visits and follow-up appointments
  • You are willing to sign a consent form before taking part in any study-related procedures

Who may not be able to join:

  • Your cancer has already spread to distant parts of the body (such as bones, lungs, or liver)
  • You have serious heart or lung problems, including a recent heart attack, uncontrolled irregular heartbeat, unstable chest pain, significant fluid around the heart, or severe lung disease
  • You have previously had radiotherapy (radiation treatment) to your chest wall or the area above your collarbone
  • You are pregnant, breastfeeding, or have any condition that your doctor believes would make radiation treatment unsafe for you
  • You have a history of another cancer, or currently have another cancer — with some exceptions, such as certain skin cancers, early-stage thyroid cancer, cervical pre-cancer, non-invasive breast cancer in the other breast, or another cancer that was fully treated more than 3 years ago with no signs of return

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Registry
ClinicalTrials.gov
Start date
1 February 2026
Est. completion
1 February 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Progression-Free Survival (PFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov